LON:FEVR - Fevertree Drinks Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 3,600 -5.00 (-0.14 %)
(As of 07/17/2018 04:12 AM ET)
Previous CloseGBX 3,605
Today's RangeGBX 3,582 - GBX 3,629
52-Week RangeGBX 1,353.93 - GBX 2,926
Volume344,646 shs
Average Volume460,543 shs
Market Capitalization£3.35 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Fevertree Drinks logoFevertree Drinks plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, naturally light tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, ginger beer, naturally light ginger beer, ginger ale, Madagascan cola, bitter lemon, lemonade, Sicilian lemonade, spring soda water, and premium cola. Fevertree Drinks plc sells its products under Fever-Tree brand name to bars and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.

Receive FEVR News and Ratings via Email

Sign-up to receive the latest news and ratings for FEVR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange LON
Industry Beverages - Soft Drinks
Sub-IndustryN/A
SectorConsumer Defensive
SymbolLON:FEVR
CUSIPN/A
Phone+44-20-73494922

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins26.53%
Return on Equity44.50%
Return on Assets33.39%

Miscellaneous

EmployeesN/A
Outstanding Shares115,240,000
Market Cap£3,350.00

The Truth About Cryptocurrencies

Fevertree Drinks (LON:FEVR) Frequently Asked Questions

What is Fevertree Drinks' stock symbol?

Fevertree Drinks trades on the London Stock Exchange (LON) under the ticker symbol "FEVR."

How often does Fevertree Drinks pay dividends? What is the dividend yield for Fevertree Drinks?

Fevertree Drinks declared a dividend on Tuesday, March 13th. Stockholders of record on Thursday, April 19th will be given a dividend of GBX 7.64 per share on Friday, May 25th. This represents a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, April 19th. This is a boost from Fevertree Drinks's previous dividend of $3.01. The official announcement can be viewed at this link. View Fevertree Drinks' Dividend History.

What price target have analysts set for FEVR?

7 analysts have issued 1-year price targets for Fevertree Drinks' stock. Their forecasts range from GBX 2,100 to GBX 4,000. On average, they expect Fevertree Drinks' stock price to reach GBX 3,030 in the next year. This suggests that the stock has a possible downside of 15.8%. View Analyst Ratings for Fevertree Drinks.

What is the consensus analysts' recommendation for Fevertree Drinks?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fevertree Drinks in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Fevertree Drinks' key competitors?

Who are Fevertree Drinks' key executives?

Fevertree Drinks' management team includes the folowing people:
  • Mr. Timothy Daniel Gray Warrillow, Co-Founder, CEO & Exec. Director (Age 43)
  • Mr. Charles Timothy Rolls, Co-Founder & Non-Exec. Deputy Chairman (Age 61)
  • Mr. Andrew J. Branchflower, Fin. Director, Company Sec. and Exec. Director (Age 39)
  • Oliver Winters, Communications & IR Director
  • Saskia Stoop, Head of Marketing (Age 34)

Has Fevertree Drinks been receiving favorable news coverage?

News headlines about FEVR stock have trended somewhat positive on Tuesday, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Fevertree Drinks earned a coverage optimism score of 0.12 on Accern's scale. They also gave media coverage about the company an impact score of 45.39 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Fevertree Drinks?

Shares of FEVR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Fevertree Drinks' stock price today?

One share of FEVR stock can currently be purchased for approximately GBX 3,600.

How big of a company is Fevertree Drinks?

Fevertree Drinks has a market capitalization of £3.35 billion.

How can I contact Fevertree Drinks?

Fevertree Drinks' mailing address is Kildare HSE, 3 Dorset Rise, LONDON, EC4Y 8EN, United Kingdom. The company can be reached via phone at +44-20-73494922.


MarketBeat Community Rating for Fevertree Drinks (LON FEVR)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  120 (Vote Underperform)
Total Votes:  298
MarketBeat's community ratings are surveys of what our community members think about Fevertree Drinks and other stocks. Vote "Outperform" if you believe FEVR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FEVR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.